
Chong Kun Dang Signs Strategic Partnership with AbClon for Innovative Biotech Development
Chong Kun Dang announced on May 9th that it has entered into a strategic equity investment and collaborative research agreement with biopharmaceutical company AbClon at its headquarters in Chungjeong-ro, Seoul. Through this partnership, Chong Kun Dang …